India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could act as surrogate promotions, as global and domestic drugmakers seek a share of the country's fast-growing obesity drug market.